Disease

Kidney Failure, Chronic

2 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

JUL 9, 2026 · JOURNAL ARTICLE

Psychological resilience mediates the impact of anxiety and insomnia on health-related quality of life in maintenance dialysis patients.

Renal Failure

Cross-sectional study with multivariable regression and mediation analysis confirms known associations and quantifies mediating pathways in a well-defined clinical population.

Important Confirmatory EvidenceSleep Initiation and Maintenance Disorders Kidney Failure, Chronic Lian Lin

Reported

Sample size207

Anxiety effect on PCS per 1-point…1.61-point decrease

Anxiety effect on MCS per 1-point…1.15-point decrease

MAY 13, 2026 · JOURNAL ARTICLE

Comparative efficacy and safety of apixaban and rivaroxaban versus warfarin in atrial fibrillation patients with end-stage renal disease: a systematic review and meta-analysis.

Renal Failure

Meta-analysis of 3 RCTs and 8 observational studies shows apixaban and rivaroxaban associated with lower bleeding risk versus warfarin in dialysis patients with AF, but efficacy endpoints show substantial heterogeneity and RCT-only analysis lacked statistical significance; evidence is suggestive but requires dedicated large RCTs.

PromisingXiaoyuan Wu Xin Liu Kidney Failure, Chronic

Reported

Major bleeding risk ratio0.57 (95% CI: 0.51–0.63)

Gastrointestinal bleeding risk ra…0.66 (95% CI: 0.57–0.76)

Intracranial hemorrhage risk ratio0.54 (95% CI: 0.36–0.83)